Literature DB >> 1634623

Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

S F Kuan1, K Rust, E Crouch.   

Abstract

Surfactant protein D (SP-D) is a collagenous glycoprotein that is secreted into the pulmonary airspaces by alveolar type II and nonciliated bronchiolar cells. SP-D exhibits Ca(++)-dependent carbohydrate binding in vitro and is structurally related to the collagenous C-type lectins, including serum conglutinin, serum mannose-binding proteins, and surfactant protein A. Preliminary studies showed calcium- and saccharide-dependent binding of fluorescein-conjugated or radioiodinated SP-D to a variety of microorganisms, including Gram-negative bacteria and fungi. A laboratory strain of Escherichia coli (Y1088) was chosen to further examine the mechanism(s) of binding. Binding of SP-D to Y1088 was time dependent, saturable, and inhibited by cold SP-D or competing saccharides; Scatchard analysis gave a Kd of 2 x 10(-11) M. At higher concentrations, SP-D also caused Ca(++)-dependent agglutination of Y1088 that was inhibited by alpha-glucosyl-containing saccharides, antisera to the carbohydrate-binding domain of SP-D, or Y1088 LPS. Lectin blots showed specific binding of 125I-SP-D to Y1088 LPS, as well as LPS from other several strains of enteric Gram-negative bacteria. Immunogold studies demonstrated strong and uniform surface labeling of the bacteria. Rat and human bronchoalveolar lavage (BAL) caused Ca(++)-dependent agglutination of E. coli that was dose dependent and inhibited by competing saccharides or anti-SP-D. SP-D was selectively and efficiently adsorbed from rat BAL by incubation with E. coli, and incubation of E. coli with radiolabeled rat type II cell medium revealed that SP-D is the major E. coli-binding protein secreted by freshly isolated cells in culture. We suggest that SP-D plays important roles in the lung's defense against Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634623      PMCID: PMC443067          DOI: 10.1172/JCI115861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Structures and functions associated with the group of mammalian lectins containing collagen-like sequences.

Authors:  S Thiel; K B Reid
Journal:  FEBS Lett       Date:  1989-06-19       Impact factor: 4.124

2.  Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae.

Authors:  S N Abraham; D Sun; J B Dale; E H Beachey
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

3.  Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis.

Authors:  U Hopf; B Möller; R Stemerowicz; H Lobeck; A Rodloff; M Freudenberg; C Galanos; D Huhn
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

4.  Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis.

Authors:  A J Tenner; S L Robinson; J Borchelt; J R Wright
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

5.  CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins.

Authors:  A Persson; K Rust; D Chang; M Moxley; W Longmore; E Crouch
Journal:  Biochemistry       Date:  1988-11-15       Impact factor: 3.162

6.  Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein.

Authors:  A Persson; D Chang; K Rust; M Moxley; W Longmore; E Crouch
Journal:  Biochemistry       Date:  1989-07-25       Impact factor: 3.162

7.  In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin.

Authors:  P Friis-Christiansen; S Thiel; S E Svehag; R Dessau; P Svendsen; O Andersen; S B Laursen; J C Jensenius
Journal:  Scand J Immunol       Date:  1990-04       Impact factor: 3.487

8.  Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.

Authors:  D E McCallus; N L Norcross
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein.

Authors:  J Weiss; M Hutzler; L Kao
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  73 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung.

Authors:  Francis X McCormack; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.

Authors:  Kevan L Hartshorn; Mitchell R White; Erika C Crouch
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis.

Authors:  F Hu; W Liang; Z Ren; G Wang; G Ding
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Authors:  P C Reading; L S Morey; E C Crouch; E M Anders
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

7.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  The cDNA cloning of conglutinin and identification of liver as a primary site of synthesis of conglutinin in members of the Bovidae.

Authors:  J Lu; S B Laursen; S Thiel; J C Jensenius; K B Reid
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

9.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Surfactant protein D binding to alveolar macrophages.

Authors:  K Miyamura; L E Leigh; J Lu; J Hopkin; A López Bernal; K B Reid
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.